ロード中...
What to do with minimal residual disease testing in myeloma
The role and use of minimal residual disease (MRD) testing has changed significantly over the past few years as it has become part of the routine care for response assessment in multiple myeloma. The most widely used standardized methods to assess MRD in myeloma in the bone marrow are multicolor flo...
保存先:
| 出版年: | Hematology Am Soc Hematol Educ Program |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Hematology
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913484/ https://ncbi.nlm.nih.gov/pubmed/31808833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000080 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|